NYSE$ZBH
Zimmer Biomet Holdings Inc · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
Zimmer Biomet reported fourth quarter and full-year results, exceeding financial guidance and making strategic moves towards portfolio diversification.
Zimmer Biomet announced Q4 2024 net sales of $2.023 billion, a 4.3% increase, with diluted earnings per share at $1.20 and adjusted diluted earnings per share at $2.31. Full-year net sales reached $7.679 billion, up 3.8%, with diluted earnings per share at $4.43 and adjusted diluted earnings per share at $8.00. The company also provided full-year 2025 financial guidance and announced an agreement to acquire Paragon 28.
- Fourth quarter net sales increased by 4.3% to $2.023 billion, or 4.9% on a constant currency basis.
- Diluted earnings per share for the fourth quarter were $1.20, with adjusted diluted earnings per share at $2.31.
- Full-year net sales reached $7.679 billion, representing a 3.8% increase, or 4.8% on a constant currency basis.
- Full-year diluted earnings per share were $4.43, and adjusted diluted earnings per share were $8.00.
Headline financials
Revenue & EPS history
Zimmer Biomet · Revenue · Quarterly
$2.02B
Revenue by segment
Zimmer Biomet · $1.59B total across 3 segments · Q3 2023
- Knees Net Sales$706M+7.5%44.3%
- Hips Net Sales$465M-0.6%29.2%
- S.E.T. Net Sales$423M+3.4%26.5%
Forward guidance
The Company is providing the following full-year 2025 financial guidance: Projected Year Ending December 31, 2025 2025 Reported Revenue Change 1.0% - 3.5% Foreign Currency Exchange Impact (2.0)% - (1.5)% 2025 Constant Currency Revenue Change 3.0% - 5.0% Adjusted Diluted EPS(1) $8.15 - $8.35
Tailwinds
- Projected Year Ending December 31, 2025
- 2025 Reported Revenue Change 1.0% - 3.5%
- Foreign Currency Exchange Impact (2.0)% - (1.5)%
- 2025 Constant Currency Revenue Change 3.0% - 5.0%
- Adjusted Diluted EPS(1) $8.15 - $8.35
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
-0.4%
Avg return
Earnings day
-1.7%
Avg return
5 days after
-2.3%
Avg return
30 days after
42%
30 / 72 earnings
Positive
+11.9%
Q3 2020
Best reaction
-15.3%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.1% | -10.5% | -11.5% | |
| Q4 2025 | +1.9% | +7.5% | +3.2% | |
| Q3 2025 | -15.2% | -14.0% | -8.6% | |
| Q1 2025 | -11.6% | -7.0% | -10.7% | |
| Q4 2024 | -5.1% | -8.6% | -0.2% | |
| Q3 2024 | +2.9% | +4.4% | +7.9% | |
| Q2 2024 | -0.8% | -2.3% | -4.3% | |
| Q1 2024 | +1.8% | +1.6% | -3.7% | |
| Q4 2023 | -3.7% | -3.4% | -0.6% | |
| Q3 2023 | -4.1% | -3.5% | +7.3% | |
| Q2 2023 | -7.1% | -8.6% | -13.8% | |
| Q1 2023 | +0.6% | -0.7% | -8.3% | |
| Q4 2022 | +0.9% | +2.6% | -0.9% | |
| Q3 2022 | -5.7% | -3.9% | +10.0% | |
| Q2 2022 | +5.3% | +3.2% | -2.7% | |
| Q1 2022 | +4.7% | -0.3% | +1.2% | |
| Q4 2021 | -2.4% | -5.4% | -1.4% | |
| Q3 2021 | -4.8% | -9.7% | -18.5% | |
| Q2 2021 | -9.1% | -8.6% | -8.5% | |
| Q1 2021 | -2.5% | -3.1% | -10.1% | |
| Q4 2020 | -0.6% | -0.2% | -1.4% | |
| Q3 2020 | +11.9% | +7.2% | +7.0% | |
| Q2 2020 | -1.5% | +2.7% | +3.5% | |
| Q1 2020 | -6.8% | -7.8% | +10.2% | |
| Q4 2019 | +6.2% | +5.3% | -13.0% | |
| Q3 2019 | +4.9% | +5.5% | +8.1% | |
| Q2 2019 | +8.6% | +9.1% | +7.9% | |
| Q1 2019 | -3.1% | -2.8% | -8.2% | |
| Q4 2018 | +7.8% | +7.9% | +14.5% | |
| Q3 2018 | -5.6% | -7.0% | -7.7% | |
| Q2 2018 | +8.0% | +7.1% | +7.1% | |
| Q1 2018 | +5.7% | +5.8% | +0.4% | |
| Q4 2017 | -0.2% | -1.3% | -10.9% | |
| Q3 2017 | -7.7% | -10.1% | -5.8% | |
| Q2 2017 | -3.8% | -6.5% | -12.1% | |
| Q1 2017 | -4.5% | -3.7% | -4.9% | |
| Q4 2016 | +2.7% | +2.4% | +2.3% | |
| Q3 2016 | -15.3% | -15.9% | -16.9% | |
| Q2 2016 | +6.9% | +6.4% | +5.6% | |
| Q1 2016 | -0.1% | — | — | |
| Q4 2015 | -2.3% | — | — | |
| Q3 2015 | +6.8% | — | — | |
| Q2 2015 | -2.7% | — | — | |
| Q1 2015 | -4.3% | — | — | |
| Q4 2014 | -2.1% | — | — | |
| Q3 2014 | +5.1% | — | — | |
| Q2 2014 | -2.3% | — | — | |
| Q1 2014 | +9.9% | — | — | |
| Q4 2013 | +0.8% | — | — | |
| Q3 2013 | -3.3% | — | — | |
| Q2 2013 | +0.5% | — | — | |
| Q1 2013 | +0.6% | — | — | |
| Q4 2012 | -1.3% | — | — | |
| Q3 2012 | +2.0% | — | — | |
| Q2 2012 | -3.5% | — | — | |
| Q1 2012 | -0.6% | — | — | |
| Q4 2011 | -1.3% | — | — | |
| Q3 2011 | +3.7% | — | — | |
| Q2 2011 | -5.6% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | +2.2% | — | — | |
| Q3 2010 | +3.6% | — | — | |
| Q2 2010 | -1.5% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q1 2010 | +1.6% | — | — | |
| Q4 2009 | -0.2% | — | — | |
| Q3 2009 | +4.0% | — | — | |
| Q3 2008 | +4.0% | — | — | |
| Q4 2007 | -1.0% | — | — | |
| Q2 2008 | -1.0% | — | — | |
| Q2 2009 | -1.0% | — | — | |
| Q4 2008 | -1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro